Controlled evaluation of nicotinamide adenine dinucleotide in the treatment of chronic schizophrenic patients.
D000328:Adult; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D007406:Interview, Psychological; D008297:Male; D008875:Middle Aged; D009243:NAD / Q000627:therapeutic use*; D010919:Placebos; D011386:Projective Techniques; D011581:Psychological Tests; D012559:Schizophrenia / Q000188:drug therapy*
D010919:Placebos; D009243:NAD